Quick Facts

Myriad Genetics Partners With Hannah Storm To Promote Breast Cancer Risk Assessment Program

Myriad Genetics Inc. (MYGN) announced an agreement with Hannah Storm, a nationally renowned sports broadcaster, who recently revealed her battle with breast cancer.

As per the deal, Storm will act as an ambassador for the Myriad Genetics
Breast Cancer Risk Assessment Program featuring the MyRisk with RiskScore
Hereditary Cancer Test, hereditary cancer test and polygenic risk prediction test for all ancestries. She will promote the importance of collecting a detailed family health history for cancer and understanding the associated cancer risks.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More Quick Facts